GA Challenge – Part 1: Become a GA Epidemiology Expert
Activity Description and Purpose
This educational activity will help clinicians become more adept at identifying patients who are at higher risk for geographic atrophy and promote early diagnosis.
This educational activity is intended for optometrists.
After completing this activity, participants will be better able to:
- Recognize epidemiologic indicators of patients who may be at higher risk for geographic atrophy
Ashkan M. Abbey, MD, FASRS, FAAO
The content of this COPE-accredited CE activity was planned and prepared independently by MedEdicus without input from members of an ineligible company. All relevant relationships with ineligible companies have been mitigated.
Ashkan M. Abbey, MD, is a consultant for Allergan, EyePoint Pharmaceuticals, and Genentech, Inc; is on the speakers bureau for Alimera Sciences, Allergan, Apellis Pharmaceuticals, Biogen Idec, Coherus Biosciences, Genentech, Inc, Iveric Bio, Inc, and Regeneron Pharmaceuticals, Inc; and is a contracted researcher for EyePoint Pharmaceuticals.
Planners, Managers, and Writers
Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.
Other MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
COPE approved for 0.25 CE credit for optometrists.
COPE Course ID: 88747-TD (Asynchronous)
COPE Course Category: Treatment/Management of Ocular Disease
This activity, COPE Activity Number 127430, is accredited by COPE for continuing education for optometrists.
Disclosure of Commercial Support
MedEdicus has received commercial support from Iveric Bio, Inc, for this activity in the form of an unrestricted educational grant.
The content of this COPE-accredited CE activity was planned and prepared independently by MedEdicus without input from members of an ineligible company.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs or devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at email@example.com.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the State University of New York College of Optometry, MedEdicus LLC, or Iveric Bio, Inc.
This CE activity is copyrighted to MedEdicus LLC ©2023. All rights reserved. 296.21a
- 0.25 COPE